Intellia Therapeutics(NTLA) - 2020 Q3 - Earnings Call Transcript

Intellia Therapeutics, Inc. (NASDAQ:NTLA) Q3 2020 Results Earnings Conference Call November 5, 2020 8:00 AM ET Company Participants Lina Li - Associate Director, IR John Leonard - President and Chief Executive Officer Laura Sepp-Lorenzino - Executive Vice President and Chief Scientific Officer Glenn Goddard - Executive Vice President, Chief Financial Officer David Lebwohl - Executive Vice President and Chief Medical Officer Conference Call Participants Salveen Richter - Goldman Sachs Maury Raycroft - Jeffer ...